Proteomics Ends Deal with US Distributor for Kidney Disease Test Kit

MT Newswires Live

Sep 11, 2024

Proteomics International Laboratories (ASX:PIQ) issued a notice of termination to Sonic Healthcare USA, the US distributor of its diabetic kidney disease test PromarkerD, effective Tuesday, after not meeting certain milestones to commercialize the test kit, according to a Wednesday filing with the Australian bourse.

Following the termination, the diagnostic firm will now market and sell PromarkerD in the US via licensing deals with service providers, pathology laboratories, and/or direct-to-consumer/patient channels, the filing said.

The company will establish a code-compliant third-party reference laboratory ahead of the test kit's launch, the filing stated.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2466341903"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2466341903\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2466341903?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-11 07:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2466341903","market":"sh","top_or_hot":-1,"title":"Proteomics Ends Deal with US Distributor for Kidney Disease Test Kit","media":"MT Newswires Live","content":"<html><body><p>Proteomics Ends Deal with US Distributor for Kidney Disease Test Kit</p><p> Proteomics International Laboratories (ASX:PIQ) issued a notice of termination to Sonic Healthcare USA, the US distributor of its diabetic kidney disease test PromarkerD, effective Tuesday, after not meeting certain milestones to commercialize the test kit, according to a Wednesday filing with the Australian bourse.</p><p>Following the termination, the diagnostic firm will now market and sell PromarkerD in the US via licensing deals with service providers, pathology laboratories, and/or direct-to-consumer/patient channels, the filing said.</p><p>The company will establish a code-compliant third-party reference laboratory ahead of the test kit's launch, the filing stated.</p></body></html>","source":"mtnewswires_live","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Proteomics Ends Deal with US Distributor for Kidney Disease Test Kit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nProteomics Ends Deal with US Distributor for Kidney Disease Test Kit\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-11 07:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Proteomics Ends Deal with US Distributor for Kidney Disease Test Kit Proteomics International Laboratories (ASX:PIQ) issued a notice of termination to Sonic Healthcare USA, the US distributor of its ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"A7RU.SI","symbol_name":"吉宝基础设施信托","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2466341903","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2466341903","pubTimestamp":1726012771,"columns":[],"sourceInfo":{"source_id":"mtnewswires_live","name":"MT Newswires Live"},"weMediaInfo":null,"summary":"Proteomics Ends Deal with US Distributor for Kidney Disease Test Kit Proteomics International Labora","collect":0,"end_time":0,"defaultTopTitle":"mtnewswires.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"A7RU.SI":"吉宝基础设施信托","SG9999004360.SGD":"Nikko AM Shenton Thrift Fund SGD","XJO.AU":"标普/澳交所 200指数","PIQ.AU":"PROTEOMICS INTERNATIONAL LAB","XAO.AU":"标普/澳交所 普通股指数","BK7048":"生命科学工具和服务","BK7508":"医药生物股","SG9999002950.SGD":"United Asian Growth Opportunities SGD","SG9999003826.SGD":"日兴资管新加坡股息基金 SGD","XKO.AU":"标普/澳交所 300指数","HCSG":"Healthcare Svcs Group Inc","BK4137":"综合支持服务","SG9999001069.SGD":"UOB UNITED ASIA PACIFIC GROWTH (SGD) ACC","SHL.AU":"SONIC HEALTHCARE LTD","BK6031":"特种化学制品","BK6102":"燃气公用事业","SG9999003461.SGD":"United Asia Pacific Infrastructure SGD","BK6501":"化工股"},"translate_title":"Proteomics终止与美国肾脏疾病检测试剂盒经销商的交易","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"A7RU.SI":1,"XKO.AU":1,"PIQ.AU":1,"SHL.AU":1,"XJO.AU":1,"HCSG":1,"XAO.AU":1},"content_text":"Proteomics Ends Deal with US Distributor for Kidney Disease Test Kit Proteomics International Laboratories (ASX:PIQ) issued a notice of termination to Sonic Healthcare USA, the US distributor of its diabetic kidney disease test PromarkerD, effective Tuesday, after not meeting certain milestones to commercialize the test kit, according to a Wednesday filing with the Australian bourse.Following the termination, the diagnostic firm will now market and sell PromarkerD in the US via licensing deals with service providers, pathology laboratories, and/or direct-to-consumer/patient channels, the filing said.The company will establish a code-compliant third-party reference laboratory ahead of the test kit's launch, the filing stated.","kind":"live","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}